Cargando…
Validation of risk prediction models for the development of HBV-related HCC: a retrospective multi-center 10-year follow-up cohort study
Recently, modified REACH-B (mREACH-B) risk prediction model for hepatocellular carcinoma (HCC) development was proposed. We validated the accuracy of the mREACH-B model and compared its accuracy with those of other prediction models. Between 2006 and 2012, 1,241 patients with chronic hepatitis B (CH...
Autores principales: | Seo, Yeon Seok, Jang, Byoung Kuk, Um, Soon Ho, Hwang, Jae Seok, Han, Kwang-Hyub, Kim, Sang Gyune, Lee, Kwan Sik, Kim, Seung Up, Kim, Young Seok, Lee, Jung Il |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762585/ https://www.ncbi.nlm.nih.gov/pubmed/29348900 http://dx.doi.org/10.18632/oncotarget.22375 |
Ejemplares similares
-
Risk Assessment of Hepatocellular Carcinoma Using Transient Elastography Vs. Liver Biopsy in Chronic Hepatitis B Patients Receiving Antiviral Therapy
por: Seo, Yeon Seok, et al.
Publicado: (2016) -
A comparative study of high-dose hepatic arterial infusion chemotherapy and transarterial chemoembolization using doxorubicin for intractable, advanced hepatocellular carcinoma
por: Kim, Hee Yeon, et al.
Publicado: (2010) -
The Influence of Histologic Inflammation on the Improvement of Liver Stiffness Values Over 1 and 3 Years
por: Yoo, Jeong-Ju, et al.
Publicado: (2019) -
Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase
por: Lee, Hye Won, et al.
Publicado: (2020) -
The HBV DNA cutoff value for discriminating patients with HBeAgnegative chronic hepatitis B from inactive carriers
por: Kim, Eun Sun, et al.
Publicado: (2011)